INTRODUCTION
C ervical cancer is the third most common malignant neoplasm among women (90% of cases in developing countries), and in Brazil it accounts for 9.3% of gynecological malignancies. Worldwide, 500,000 new cases per year are diagnosed, accounting for 250,000 annual deaths 1 . The National Cancer Institute (INCA) recommends that cervical cytopathological screening be done every three years after two consecutive negative tests in patients aged 25 and 64 years, provided that the samples are satisfactory and representative of the squamous-column junction 2 . The malignant neoplasm of the cervix is preceded by a long phase of precursor, usually asymptomatic, lesion, characterized by cervical intraepithelial neoplasia (CIN), which may persist for 10 to 20 years.
In 1976, Zur Hausen 3 demonstrated the relationship between the HPV virus infection and the onset of genital tract neoplasias. Infection is more common in young patients; however, sexual behavior, age, smoking, parity and use of contraceptives are also risk factors for this neoplasia 1 . On the other hand, not all patients infected with the virus have the same disease progression, since this behavior is linked to environmental factors, immunity, host genetics and cellular factors 4 . The use of molecular markers has helped the pathologists in the definition of doubtful cases and in the identification of women at high risk for disease recurrence after treatment of cervical intraepithelial neoplasias 5 . p16 ink4a , a tumor suppressor protein, is overexpressed in cases of dysplasia, presenting a high sensitivity as it correlates with the dysplasia severity. Current studies indicate that p16 ink4a is a useful biomarker for high-risk lesions and for progression prediction in low-risk ones. These studies show a significant association between the degree of cervical lesion and the distribution and intensity of p16 ink4a expression 5, 6 . Ki67 is another cell proliferation marker expressed at all stages of the cell cycle, except in the G0 phase, and which, although not specifically involved in the cervical carcinogenic process, has an independent predictive value as to grading and evaluating disease progression 7 . Telomerase is a ribonucleic enzyme complex that allows telomere maintenance in 90% of cancer cases. In normal somatic cells, telomerase activity is low or undetectable, and telomeres shorten at each cell division. The hTert is the telomerase reverse transcriptase, being the most important factor in the formation of functional telomerase. The activation of telomerase establishes telomere length maintenance, acting in the transformation of dysplasia into malignant neoplastic alterations and in the maintenance of phenotypically more aggressive cell populations 8 . The hTert is present in 28.5% of CIN I, in 87.5% of CIN II and in 95% of CIN III 9 . Among the existing treatments for the management of cervical intraepithelial neoplasias, in our hospital we perform the conization and the electrosurgical excision of the transformation zone (LEEP) techniques. The former has the advantage of allowing lesion resection and margins evaluating without the presence of fulguration artifacts by the passage of electric current, but removes a larger volume of cervical stroma, which can lead to adverse reproductive outcomes. The LEEP technique is a technically simpler procedure, which can be done in an outpatient setting under local anesthesia. On the other hand, margins may be inadequate for evaluation due to histological artifacts caused by thermal damage, have a higher risk of bleeding and may cause cervical stenosis in up to 6% of patients 10 . The literature recommends that patients'followup should be for at least one year with a cervical cytopathological exam (CP) and with semestral colposcopy after surgery, since this is the period of greatest risk of recurrence of cervical lesions 11 . The recurrence rate of high-grade intraepithelial lesions after surgical excision varies from 5% to 10% 4, 12, 13 . The complication associated with the surgical treatment of such lesions are bleeding, external cervical orifice stenosis, infertility, shortening of the cervix and risk of preterm labor, isthmo-cervical incompetence, low birth weight fetuses, cesarean section and premature membranes rupture 14 . Therefore, to analyze the association between recurrence after surgical treatment and the expression of immunohistochemical markers according to the graduation of high and low grade intraepithelial lesions would allow the suspension of a rigorous clinical follow-up and the reduction of overdiagnosis and overtreatment in patients affected by this disease. To date, there is no description of the concomitant evaluation of the three immunohistochemical markers -p16 ink4a , Ki67 and hTert -in high and low grade intraepithelial lesions. As already described, the only marker that has well established utility in the evaluation of progression, not recurrence, of these lesions is p16 ink4a 15 . Other markers are still poorly studied and, therefore, there are few published papers regarding Ki67 and hTert, with no established accuracy for use in clinical practice, although they appear to display a difference according to their expression between high and low grade lesions 16 . Furthermore, the behavior of CIN II is still uncertain, and so far, this lesion receives the same treatment as CIN III, a standardized conduct based on the 1991 Bethesda consensus 17 . However, in recent years, its aggressiveness has been questioned, since it behaves dubiously, with a significant number of cases showing good evolution, spontaneous regression or indolent behavior 6, 7 . The establishment of recurrence risk markers for this type of lesion is thus innovative, and could define which patients would require surgical treatment and which would be likely to remain in clinical follow-up. This answer does not yet exist in the literature.
METHODS
We studieda historical cohort in which we analyzed 94 patients divided into three groups with cervical intraepithelial lesions, CIN I, CIN II and CIN III, submitted to conization or LEEP. We followed the patients for two years to determine disease recurrence. The sample consisted of patients from the Gynecology outpatient clinic of the São Lucas Hospital of the Pontifical Catholic University of Rio Grande do Sul (PUCRS), who underwent cervical cytopathological examination followed by colposcopy with biopsy of suspicious areas and subsequent diagnosis of CIN. We recruited patients by (consecutive) convenience sampling. All cases of the study had the histological examinations reviewed by a second pathologist with clinical experience superior to twenty years.
Inclusion criteria were patients aged 18 years or older, submitted to LEEP or conization, and with a six-month postoperative follow-up (cervical CP, colposcopy and cervix biopsy if necessary) for at least two years, whose surgical specimens had margins free of cervical intraepithelial neoplasia. Exclusion criteria were patients with human immunodeficiency virus (HIV) or other immunosuppressive disorders, and pregnancy.
We performed the immunohistochemistry technique on tissues fixed in formalin and included in paraffin. The detection method used for screening tissue antigens was avidin-biotin peroxidase. We produced 3-μm thick histological sections on a Leica RT2150 rotary microtome. The slides were deparaffinized in a histological oven at 69° C, two incubations in xylol, five incubations with 99° ethyl alcohol, washing in running water until complete removal and then maintained in a PBS buffer. Antigen retrieval utilized a 6.0-pH citrate buffer for 20 minutes. Endogenous peroxidase activity was blocked with 5% hydrogen peroxide solution in methyl alcohol. Incubation with the primary antibody was performed in a BOD incubator at 5°C. To detect the antigenantibody reaction, we used biotinylated secondary antibody and avidin-HRP complex. We performed staining with Diamine Benzidine (DAB, DAKO) as the chromogen. Finally,we counterstained the slides with Harris haematoxylin, dehydrated in a series of 99° ethyl alcohol, clarified in xylene and mounted with Canadian balsam. The clones used for the markers were E6H4 to p16 ink4a , MM1 to Ki67 and 2C4 to hTert. For the detection of p16 ink4a , Ki67 and hTert, we used slides without cervical intraepithelial neoplasia as negative controls and, as positive controls, slides with high cervical intraepithelial neoplasia (CIN III). Regarding the interpretation of the markers, we considered the nuclear staining as positive for the cells expressing p16 ink4a . We graded the expression intensity for p16 ink4a in CIN as negative if none of the cells displayed staining, and as positive, if they expressed staining as a percentage (less than 10%, 11% to 50% or more than 50%). We considered Ki67 positive only if the nuclei of the cells showed staining and we determined the percentage of cells expressing it in less than 10%, 11% to 50% or more than 50%. We considered hTert positive also if the cell nucleus was stained. The expression was considered positive if the cells expressed staining and negative when there was no expression.
We inputted the data in the Excel 2010 software and later exported to the SPSS v.20.0 program for statistical analysis. We described categorical variables by frequencies and percentages and analyzed them with the Chi-square test. We described the quantitative variables with symmetrical distribution by the mean and standard deviation, comparing two categories with the Student t test for independent samples, and three categories or more, with the Analysis of Variance (ANOVA) test. We described quantitative variables with asymmetric distribution by median and the interquartile range (25th and 75th percentiles), comparing two categories with the Mann-Whitney test, and three or more categories, with the Kruskal-Wallis test. We set the significance level at 5%. 
RESULTS
Patients' mean age was 38 years, with a standard deviation of 11.7; 37% used combined oral contraceptives and 26% did not use any contraceptive method. Only 31% were smokers, the mean number of children was two and the average of the first intercourse was at 16 years. The surgical approach was conization in 79.8% of patients. The most frequent anatomic and pathological findings were CIN III (52%), followed by CIN I (14.9%) and The total number of recurrences among the 94 patients operated, regardless of the type of procedure, was 23 (24.5%). Recurrence was more common in patients who underwent LEEP, 31%, being 22% in those submitted to conization. There was a statistically significant association between p16 ink4a and Ki67 and histological grade, as shown in Table 1 . Figures 1, 2 and 3 show the expression of immunohistochemical markers.
There was no statistically significant difference between age, smoking, parity, age of first sexual intercourse and number of sexual partners and the different histological grades ordisease recurrence. When comparing the markers between subjects with and without recurrence, there were also no statistically significant differences.
DISCUSSION
Cervical carcinoma has a high potential for prevention. In our country, however, it is a public health problem.Studies have shown high incidence and mortality in developing countries, andgood control in developed countries whose screening programs are effective 18 . Works have found that the immunohistochemical markers p16 ink4a and Ki67 are more accurate in identifying precursor lesions in patients under 30 years with cervical cytopathological examination compatible with low grade intraepithelial lesion. The expression of these markers is associated with the severity of histological lesions. In the Possati-Resende et al. study 18 , patients underwent cervical biopsy, ink4a was overexpressed by the immunohistochemical method in more than 50% of the cells of each sample in 43.3% of the cases, presenting a strong intensity in 48.9% of the exams. The Ki67 marker was expressed in 43.6% of the cases (positive in more than 50% of the sample). The hTert was positive in 56.5% of the cases studied.
Although the incidence of cervical neoplasms has decreased, there are still many diagnoses of cancer in cervical lesions with a high potential for regression and, consequently, of inadequate and excessive treatments. In this context, the use of immunohistochemical markers helps the pathologist in the histological evaluation of such lesions 19 . According to American guidelines, patients with suspected high-grade cervical intraepithelial neoplasia and overexpressed p16 ink4a benefit from surgical treatment. The positivity for this marker is linked to the onset of oncogenic transformation for the development of cancer and its use would allow the detection of pre-neoplastic lesions and the reduction of unnecessary aggressive treatments 19 . The importance of studying these markers is due to the wide variability of interpretation among observers and the poor reproducibility of cytomorphological criteria, mainly regarding the use of hematoxylin and eosin for the histological diagnosis of cervical intraepithelial neoplasias, as well as its classification in the categoriesCIN I, II and III. We minimized this limitation in this study through the evaluation and concordance of diagnosis by two pathologists, one original interpreter of the case and one reviewer. The use of these markers complements the doubtful diagnoses, avoiding unnecessary treatments 20, 21 . The presence of Ki67 in CIN I and CIN II in uterine cervix specimens is a strong independent predictive factor for graduation and disease progression, in addition to displaying an interobserver reproducibility of 100% 22 . The literature shows that the evaluated immunohistochemical markers, p16 ink4a , Ki67 and hTert, are clearly associated with histological grade. Some studies have found an association with the risk of progression to high-grade neoplasias and cancer, but none showed that their overexpression is associated with recurrence after treatment.
The CIN recurrence rate usually ranges from 5% to 10% 4, 12, 13 . However, in the study by Serati et al. 23 , who followed patients for ten years, recurrence occurred in 19.4% of the free-margin excisions and was twice as common with the LEEP technique. Although we included in our study only surgical pieces with free margins, the incidence of recurrence of 24.5% was high when compared with the rates described in the literature. On the other hand, Malapati et al. 24 followed 717 eligible patients after LEEP and observed postoperative persistence/recurrence of 24.7%. The most common type of recurrence was CIN I (47.8%), followed by CIN III (34.8%), and most occurred within the first six months after treatment (56%). There was no difference between the expression of the analyzed immunohistochemical markers and disease recurrence, even when evaluated individually at each histological grade. This fact may be due to the small number of cases and the subdivision of the markers expression positivity in below 10%, 11-50% and greater than 50%, unlike other studies in which the quantitative analysis was made in absolute numbers, a method that still presents limitations for implementation in the surgical pathology diagnostic routine. The study by Cardoso et al. 4 was one of the few that showed statistical significance between p16 ink4a overexpression and disease recurrence, as did Nam et al. 25 . Fonseca et al. 26 demonstrated that p16 ink4a was overexpressed in 43% of the recurrences, with high intensity in 58% of them, though this finding was not statistically significant. In a group of 90 patients with cervical intraepithelial neoplasia with overexpressed p16 ink4a and Ki67, there was progression in 15 cases (17%), two cases in the group of 25 patients with CIN I (8%) and 13 cases in the group of 65 patients with CIN II (20%) 22 . In our study, Ki67 expression was positive in 10% or less in CIN I and overexpressed in more than 50% of each sample in 53% of CIN II and 55% of CIN III (p=0.032).
Age, smoking, number of children, age of first intercourse, and number of sexual partners showed no significant difference in disease recurrence. Contrary to our findings, the literature shows that age greater than or equal to 35 years and smoking are risk factors for recurrence, as well as larger cytological alterations, high-risk preoperative HPV infection, positive endocervical margins, and HIV infection 24, 27, 28 . The expression of p16 ink4a related significantly to the histological grade in this study. It was negative in 53% of CIN I, overexpressed in more than 50% of CIN III in 58% of cases and expressed in a lower percentage (equal or less than 10%) in 38.5% of the cases of CIN II (p=0.026). We observed a lower percentage of positivity for p16 ink4a in CIN II than in CIN III, although both overexpressed this marker with high intensity (53.8% of CIN II and 62.5% of CIN III). In the study of Genovés 6 , evaluating 92 patients, p16
ink4a was overexpressed in seven of the 54 patients with CIN I and in 17 of the 23 patients with CIN II. The study emphasizes that the diagnosis of CIN II should not rely solely on the positivity of this marker, and its absence does not imply lesionregression.
Regarding the risk of progression, a study evaluating 52 patients with CIN II showed disease regression in 28 cases, progression to CIN III in 13 and persistence of the lesion in 11 cases. In those who progressed, 91% of the lesions had overexpressed p16 ink4a , with strong intensity 29 . As for hTert, the literature also describes its overexpression in highgrade intraepithelial lesions (p<0.001) in 88% to 90% of the samples, while low-grade intraepithelial lesions have low expression in 94% of cases 30 . It can be inferred that the expression of this marker represents an early manifestation of the dysplastic process, therefore being overexpressed in 45% of CIN I, 70% of CIN II and 80% (p=0.024) 31 . In our study, hTert did not show statistical significance in relation to the histological grade (p=0.677), although it was positive in 62.5% of the NCI III, 53.8% of CIN II and 50% of CIN I. Although the expression of immunohistochemical markers was positive in CIN II and CIN III, we observedvariable expression, showing a more intense and higher percentage of cells in high grade dysplasia. Such behavior of CIN II shows that this lesion probably has a behavior of lower aggressiveness when compared to CIN III. According to Wilkinson et al. 32 , the regression rate of CIN II is similar to that of CIN I in a follow-up of two years (17%x12%). This poses a risk of overtreatment of such lesions, mainly in women under 25 years of age, since the risk of developing cervical cancer in untreated women with high-grade dysplasia is less than 1.5%.
Despite the importance of the use of immunohistochemical markers in the progression of cervical intraepithelial neoplasias, also evidenced in our study, there was no association between the markers and the recurrence of dysplastic lesions. New studies are needed, as well as the prospection of new markers, to establish with better precision the characteristics of these lesions and to allow conservative management in those that present a more indolent behavior.
